Malaria transmission structure in the Peruvian Amazon through antibody signatures to Plasmodium vivax.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
17
09
2021
accepted:
12
04
2022
revised:
19
05
2022
pubmed:
10
5
2022
medline:
24
5
2022
entrez:
9
5
2022
Statut:
epublish
Résumé
The landscape of malaria transmission in the Peruvian Amazon is temporally and spatially heterogeneous, presenting different micro-geographies with particular epidemiologies. Most cases are asymptomatic and escape routine malaria surveillance based on light microscopy (LM). Following the implementation of control programs in this region, new approaches to stratify transmission and direct efforts at an individual and community level are needed. Antibody responses to serological exposure markers (SEM) to Plasmodium vivax have proven diagnostic performance to identify people exposed in the previous 9 months. We measured antibody responses against 8 SEM to identify recently exposed people and determine the transmission dynamics of P. vivax in peri-urban (Iquitos) and riverine (Mazán) communities of Loreto, communities that have seen significant recent reductions in malaria transmission. Socio-demographic, geo-reference, LM and qPCR diagnosis data were collected from two cross-sectional surveys. Spatial and multilevel analyses were implemented to describe the distribution of seropositive cases and the risk factors associated with exposure to P. vivax. Low local transmission was detected by qPCR in both Iquitos (5.3%) and Mazán (2.7%); however, seroprevalence indicated a higher level of (past) exposure to P. vivax in Mazán (56.5%) than Iquitos (38.2%). Age and being male were factors associated with high odds of being seropositive in both sites. Higher antibody levels were found in individuals >15 years old. The persistence of long-lived antibodies in these individuals could overestimate the detection of recent exposure. Antibody levels in younger populations (<15 years old) could be a better indicator of recent exposure to P. vivax. The large number of current and past infections detected by SEMs allows for detailed local epidemiological analyses, in contrast to data from qPCR prevalence surveys which did not produce statistically significant associations. Serological surveillance will be increasingly important in the Peruvian Amazon as malaria transmission is reduced by continued control and elimination efforts.
Sections du résumé
BACKGROUND
The landscape of malaria transmission in the Peruvian Amazon is temporally and spatially heterogeneous, presenting different micro-geographies with particular epidemiologies. Most cases are asymptomatic and escape routine malaria surveillance based on light microscopy (LM). Following the implementation of control programs in this region, new approaches to stratify transmission and direct efforts at an individual and community level are needed. Antibody responses to serological exposure markers (SEM) to Plasmodium vivax have proven diagnostic performance to identify people exposed in the previous 9 months.
METHODOLOGY
We measured antibody responses against 8 SEM to identify recently exposed people and determine the transmission dynamics of P. vivax in peri-urban (Iquitos) and riverine (Mazán) communities of Loreto, communities that have seen significant recent reductions in malaria transmission. Socio-demographic, geo-reference, LM and qPCR diagnosis data were collected from two cross-sectional surveys. Spatial and multilevel analyses were implemented to describe the distribution of seropositive cases and the risk factors associated with exposure to P. vivax.
PRINCIPAL FINDINGS
Low local transmission was detected by qPCR in both Iquitos (5.3%) and Mazán (2.7%); however, seroprevalence indicated a higher level of (past) exposure to P. vivax in Mazán (56.5%) than Iquitos (38.2%). Age and being male were factors associated with high odds of being seropositive in both sites. Higher antibody levels were found in individuals >15 years old. The persistence of long-lived antibodies in these individuals could overestimate the detection of recent exposure. Antibody levels in younger populations (<15 years old) could be a better indicator of recent exposure to P. vivax.
CONCLUSIONS
The large number of current and past infections detected by SEMs allows for detailed local epidemiological analyses, in contrast to data from qPCR prevalence surveys which did not produce statistically significant associations. Serological surveillance will be increasingly important in the Peruvian Amazon as malaria transmission is reduced by continued control and elimination efforts.
Identifiants
pubmed: 35533146
doi: 10.1371/journal.pntd.0010415
pii: PNTD-D-21-01381
pmc: PMC9119515
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010415Subventions
Organisme : NIAID NIH HHS
ID : U19 AI089681
Pays : United States
Déclaration de conflit d'intérêts
I have read the journal’s policy and the authors of this manuscript have the following competing interests: MTW and IM are inventors on patent PCT/US17/67926 on a system, method, apparatus and diagnostic test for Plasmodium vivax. No other authors declare a conflict of interest.
Références
PLoS Negl Trop Dis. 2021 Feb 16;15(2):e0009165
pubmed: 33591976
Acta Trop. 2012 Mar;121(3):292-302
pubmed: 22100446
Am J Trop Med Hyg. 2006 Jan;74(1):3-11
pubmed: 16407338
PLoS Negl Trop Dis. 2017 Feb 23;11(2):e0005337
pubmed: 28231248
Pathogens. 2021 Mar 02;10(3):
pubmed: 33801386
PLoS One. 2015 Sep 10;10(9):e0137458
pubmed: 26356311
Malar J. 2005 Jun 23;4:27
pubmed: 15975146
SSM Popul Health. 2018 May 19;5:33-37
pubmed: 29892693
Parasit Vectors. 2019 Jul 29;12(1):374
pubmed: 31358033
Malar J. 2020 Sep 3;19(1):319
pubmed: 32883308
Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):133-144
pubmed: 27799639
Sci Rep. 2017 Aug 14;7(1):8082
pubmed: 28808240
Online J Public Health Inform. 2014 Feb 05;5(3):228
pubmed: 24678381
Gates Open Res. 2019 Feb 12;3:131
pubmed: 31172051
Malar J. 2017 Aug 4;16(1):312
pubmed: 28778210
J Infect Dis. 2021 Apr 27;223(12 Suppl 2):S99-S110
pubmed: 33906225
EClinicalMedicine. 2022 Feb 14;44:101272
pubmed: 35198913
J Epidemiol Community Health. 2005 Jun;59(6):443-9
pubmed: 15911637
PLoS One. 2019 Aug 9;14(8):e0220980
pubmed: 31398228
Nat Med. 2020 May;26(5):741-749
pubmed: 32405064
Int J Environ Res Public Health. 2018 Nov 27;15(12):
pubmed: 30486449
Malar J. 2017 Apr 28;16(1):178
pubmed: 28454546